Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02440859PMID 8405013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man

  2004cited by this paper
• Incidence of S‐mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics

  1992cited by this paper
• Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype

  1990cited by this paper
• Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P‐450 human‐2

  1990cited by this paper
• Recent Developments in Hepatic Drug Oxidation Implications for Clinical Pharmacokinetics

  1990cited by this paper
• Genetic polymorphism of S-mephenytoin hydroxylation.

  1989cited by this paper
• Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S‐mephenytoin, but not debrisoquin, hydroxylation phenotype

  1989cited by this paper
• Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese

  1989cited by this paper
• Human drug metabolism in vitro.

  1988cited by this paper
• Structures and chromatographic characteristics of capsule-type silica gels coated with hydrophobic polymers in reversed-phase liquid chromatography

  1987cited by this paper
• Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes.

  1987cited by this paper
• Mephenytoin metabolism in vitro by human liver.

  1985cited by this paper
• In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase.

  1985cited by this paper
• Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography.

  1985cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Lack of inhibitory effect of wood creosote on cytochrome P450‐mediated drug metabolism

  2021cites this paper
• Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19.

  2013cites this paper
• In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong

  2012cites this paper
• 17,20-lyase inhibitors. Part 4: design, synthesis and structure-activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitors.

  2011cites this paper
• Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer.

  2011cites this paper
• Validated assays for human cytochrome P450 activities.

  2004cites this paper
• Expression of Human CYPs in Chimeric Mice with Humanized Liver

  2004cites this paper
• Inhibitory Effects of the Monoamine Oxidase Inhibitor Tranylcypromine on the Cytochrome P450 Enzymes CYP2C19, CYP2C9, and CYP2D6

  2004cites this paper
• Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities.

  2004cites this paper
• Identification of human p450 isoforms involved in the metabolism of the antiallergic drug, oxatomide, and its inhibitory effect on enzyme activity.

  2004cites this paper
• EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER

  2004cites this paper
• CYP isoforms involved in the metabolism of clarithromycin in vitro: comparison between the identification from disappearance rate and that from formation rate of metabolites.

  2003cites this paper
• Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate.

  2003cites this paper
• Molecular cloning of monkey CYP2C43 cDNA and expression in yeast.

  2002cites this paper
• Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans.

  2002cites this paper
• Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes.

  2001cites this paper
• Characterization of moclobemide N-oxidation in human liver microsomes

  2001cites this paper
• A comparison of aroclor 1254-induced and uninduced rat liver microsomes to human liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4'-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6beta-hydroxylation.

  2001cites this paper
• In vitro cytochrome P450-mediated hepatic activities for five substrates in specific pathogen free chickens.

  2001cites this paper
• Role of CYP2C19 in stereoselective hydroxylation of mephobarbital by human liver microsomes.

  2001cites this paper
• An in vitro reporter gene assay method incorporating metabolic activation with human and rat S9 or liver microsomes.

  2001cites this paper
• In vivo and in vitro studies on drug metabolism and interactions involving mibefradil, isradipine, lidocaine, selegiline and metronidazole

  2001cites this paper
• Identification of cytochrome P-450 isoform(s) responsible for the metabolism of pimobendan in human liver microsomes.

  2000cites this paper
• Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes.

  2000cites this paper
• Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate.

  2000cites this paper
• A rapid electron-capture gas chromatographic procedure for the analysis of p-hydroxymephenytoin.

  2000cites this paper
• The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate.

  2000cites this paper
• Role of human CYP2B6 in S-mephobarbital N-demethylation.

  1999cites this paper
• Identification of human cytochrome P-450 isoforms involved in metabolism of R(+)- and S(-)-gallopamil: utility of in vitro disappearance rate.

  1999cites this paper
• Inhibition and induction of human cytochrome P450 (CYP) enzymes.

  1998cites this paper
• Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4.

  1998cites this paper
• Application of a generic fast gradient liquid chromatography tandem mass spectrometry method for the analysis of cytochrome P450 probe substrates.

  1998cites this paper
• Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities.

  1998cites this paper
• A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes.

  1998cites this paper
• Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2.

  1998cites this paper
• Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes.

  1997cites this paper
• The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A.

  1996cites this paper
• Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.

  1996cites this paper
• Simple and selective assay of 4-hydroxymephenytoin in human urine using solid-phase extraction and high-performance liquid chromatography with electrochemical detection and its preliminary application to phenotyping test.

  1996cites this paper
• Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.

  1996cites this paper
• Advances in sample preparation, electrophoretic separation and detection methods for rat cytochrome P450 enzymes.

  1996cites this paper
• Genetic analysis of the S‐mephenytoin polymorphism in a chinese population

  1995cites this paper
• High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans.

  1995cites this paper
• The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes.

  1995cites this paper
• Characterization of monkey cytochrome P450, P450 CMLd, responsible for S-mephenytoin 4-hydroxylation in hepatic microsomes of cynomolgus monkeys.

  1994cites this paper
• Development and preliminary application of a high-performance liquid chromatographic assay for omeprazole metabolism in human liver microsomes.

  1994cites this paper
• The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation.

  1994cites this paper